臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jia horng kao"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 291-340 / 1180 (共24頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-09-04T06:12:28Z	Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients	Chu C.-H.; Yang A.-M.; JIA-HORNG KAO; Liu C.-Y.; Chang W.-H.; Yang W.-S.
臺大學術典藏	2021-09-04T06:12:27Z	High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection	Liu C.-J.; Chen P.-J.; Lai M.-Y.; Liu C.-H.; Chen C.-L.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:12:27Z	Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy	Liu C.-H.; Liang C.-C.; Liu C.-J.; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:27Z	Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses	Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D.
臺大學術典藏	2021-09-04T06:12:26Z	Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy	Hsu C.-S.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:26Z	Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B	Liu C.-J.; Jeng Y.-M.; Chen C.-L.; Cheng H.-R.; Chen P.-J.; Chen T.-C.; Liu C.-H.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:25Z	Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy	Tseng T.-C.; Liu C.-J.; Hsieh S.-C.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:25Z	IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients	Chuang J.Y.; Yang S.S.; Lu Y.T.; Hsieh Y.Y.; Chen C.Y.; Chang S.C.; Chang C.S.; Yeh H.Z.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:24Z	Telaprevir for chronic HCV infection	JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:24Z	Esomeprazole for asthma [7]	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:24Z	HBV genotypes and chronicification of acute hepatitis B: More questions than answers	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:24Z	Capsule endoscopy versus colonoscopy	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:24Z	Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis	Tong M.J.; Hsien C.; Song J.J.; JIA-HORNG KAO; Sun H.-E.; Hsu L.; Han S.-H.; Durazo F.A.; Saab S.; Blatt L.M.
臺大學術典藏	2021-09-04T06:12:23Z	Hepatitis C virus infection, lipids, and coronary heart disease: A Pandora's box	Wang C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:23Z	Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease	Hsu C.-S.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:23Z	Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:22Z	Outcomes of HCV treatment: Who does well and who does not?	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:22Z	Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection	Hsu C.-S.; Liu C.-H.; Liu C.-J.; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:22Z	Role of Viral Factors in Modifying Weight-Related Effects on Disease Progression of Chronic Hepatitis C Patients	Hsu C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:22Z	Alanine aminotransferase, metabolic syndrome, and cardiovascular disease: A missing link	Wang C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:21Z	Optimal management of hepatocellular carcinoma: Challenges and opportunities	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:21Z	Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: A ten-year observation	Huang Z.-S.; Huang T.-S.; Wu T.-H.; Chen M.-F.; Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:21Z	The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C	Liu C.-H.; Liang C.-C.; Liu C.-J.; Hsu S.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:20Z	Intrathecal delivery of a mutant μ-opioid receptor activated by naloxone as a possible antinociceptive paradigm	JIA-HORNG KAO; Chen S.L.; Ma H.I.; Law P.Y.; Tao P.L.; Loh H.H.
臺大學術典藏	2021-09-04T06:12:20Z	Clinical implications of hepatitis B virus variants	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:20Z	Hepatitis C infection and metabolic syndrome.	Hsu C.S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:19Z	Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan	Huang Y.-W.; Liao Y.-T.; Chen W.; Chen C.-L.; Hu J.-T.; Liu C.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Yang S.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:19Z	Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma. Epidemiologic and molecular biological aspects	JIA-HORNG KAO; Chen P.-J.; Chen D.-S.
臺大學術典藏	2021-09-04T06:12:19Z	Recent advances in clinical application of gut hormones	Tseng P.-H.; Wu M.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:18Z	Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection	Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; Tseng T.-C.; Chen C.-H.; Su W.-C.; Liu C.-J.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:18Z	Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B	Su T.-H.; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:17Z	Metabolic syndrome on top of chronic hepatitis B: The more, the worse?	Chang L.-C.; Chung C.-S.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:17Z	Carvedilol versus variceal band ligation for prevention of the first variceal bleed	Wang C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:17Z	Metformin improves sustained virologic response in difficult-to-cure hepatitis c: More questions than answers	Wang C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:17Z	From liver markers to life expectancy	Wang C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:16Z	Cost-effectiveness analysis of roadmap models in chronic hepatitis B using tenofovir as the rescue therapy	Lui Y.Y.-N.; Tsoi K.K.-F.; Wong V.W.-S.; JIA-HORNG KAO; Hou J.-L.; Teo E.-K.; Mohamed R.; Piratvisuth T.; Han K.-H.; Mihm U.; Wong G.L.-H.; Chan H.L.-Y.
臺大學術典藏	2021-09-04T06:12:16Z	Letter to the editor	Wang C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:16Z	Use of statins and gallstone risk [1]	Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:15Z	Rifaximin treatment in hepatic encephalopathy [1]	Wang C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:15Z	Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B	Huang Y.-W.; Chayama K.; Tsuge M.; Takahashi S.; Hatakeyama T.; Abe H.; Hu J.-T.; Liu C.-J.; Lai M.-Y.; Chen D.-S.; Yang S.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:15Z	A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection	Tong M.J.; Hsu L.; Hsien C.; JIA-HORNG KAO; Durazo F.A.; Saab S.; Blatt L.M.
臺大學術典藏	2021-09-04T06:12:14Z	Treatment of chronic hepatitis B in Asia-Pacific countries: Is the Asia-Pacific consensus statement being followed?	Sung J.J.Y.; Amarapurkar D.; Chan H.L.Y.; Cheng J.; JIA-HORNG KAO; Han K.-H.; Piratvisuth T.
臺大學術典藏	2021-09-04T06:12:14Z	Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C	Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:14Z	HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses	Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; JIA-HORNG KAO; Lai M.-Y.; Liu C.-H.; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; Liu C.-J.; Chen D.-S.
臺大學術典藏	2021-09-04T06:12:13Z	Treatment of hepatitis C virus infection in patients with end-stage renal disease	Liu C.-H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:13Z	Implications of hepatitis B virus genomic variations on treatment outcomes	Tseng T.-C.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:13Z	The clinical implications of hepatitis B virus genotype: Recent advances	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:13Z	Hepatitis B e antigen seroconversion: A critical event in chronic hepatitis B virus Infection	Liaw Y.-F.; Lau G.K.K.; JIA-HORNG KAO; Gane E.
臺大學術典藏	2021-09-04T06:12:12Z	Entecavir: A review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease	Keating G.M.; Buti M.; Gadano A.; JIA-HORNG KAO; Lee C.-M.; Peng C.-Y.; Schiff E.R.; Tanwandee T.
臺大學術典藏	2021-09-04T06:12:12Z	Interleukin-28B genetic variations and response to interferon-based therapy: Asian perspectives	Liu C.-H.; JIA-HORNG KAO

顯示項目 291-340 / 1180 (共24頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51508758 線上人數 : 874 教育部委託研究計畫計畫執行:國立臺灣大學圖書館